*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
No Data found.
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Overview of Adherence and Influencing Factors to Capecitabine In Cancer Patients: Systematic Review

Author: ATIKA WAHYU PUSPITASARI, SUSI ARI KRISTINA, SATIBI, YAYI SURYO PRABANDARI
Abstract: Background: The increasing use of oral chemotherapy recently faces new challenges in treatment adherence. This systematic review aimed to assess rates and influencing factors of adherence to capecitabine in cancer patients. Methods: A Systematic review was conducted on online databases at PubMed, Scopus, Sage, and Science direct. A combination of relevant terminology such as "adherence," "cancer patient," "capecitabine," "influencing factors," and "contributing factors" was performed for the search. We included articles published in English from 2010 to 2020. Two researchers independently extracted data relevant to the characteristics of the study. Results: We included and systematically reviewed nine articles. The adherence level varied from 51,2% to 100%, depending on study design, adherence threshold and assessment method, and length of follow up period. Factor consistently influencing adherence in most studies is side effects. Conclusions: Adherence factors to capecitabine therapy are multifactorial. Adverse events were the main factor influencing adherence to capecitabine in most of the studies. Health care intervention is needed to promote treatment adherence among cancer patients taking capecitabine.
Keyword: compliance, oral chemotherapy, cancer, capecitabine, contributing factors
DOI: https://doi.org/10.31838/ijpr/2021.13.01.476
Download: Request For Article
 
Clients

Clients

Clients

Clients

Clients
ONLINE SUBMISSION
USER LOGIN
Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free